Enochian Biosciences Inc - FORM 10-Q - EX-32.1 - 32.1 CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - August 20, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Enochian Biosciences IncFinancial_Report.xls
EX-32.2 - 32.2 CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - Enochian Biosciences Incf10q0612ex32ii_putnam.htm
EX-31.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2012. - Enochian Biosciences Incf10q0612ex31ii_putnam.htm
10-Q - QUARTERLY REPORT - Enochian Biosciences Incf10q0612_putnam.htm
EX-31.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2012. - Enochian Biosciences Incf10q0612ex31i_putnam.htm
Exhibit 32.1

Certification of Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Putnam Hills Corp. (the "Company") on Form 10-Q for the period ending June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Samir N. Masri, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 /s/ Samir N. Masri  
  Samir N. Masri  
  Principal Executive Officer
August 20, 2012
  
 

Enochian Biosciences Inc Reports